BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28324341)

  • 1. Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study.
    Li P; Hsiao IT; Liu CY; Chen CH; Huang SY; Yen TC; Wu KY; Lin KJ
    EJNMMI Res; 2017 Dec; 7(1):24. PubMed ID: 28324341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography.
    Wu KY; Hsiao IT; Chen CS; Chen CH; Hsieh CJ; Wai YY; Chang CJ; Tseng HJ; Yen TC; Liu CY; Lin KJ
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):714-22. PubMed ID: 24233127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Cerebral Amyloid-β Depositions in Patients With a Lifetime History of Major Depression With Suspected Non-Alzheimer Pathophysiology.
    Wu KY; Lin KJ; Chen CH; Liu CY; Wu YM; Chen CS; Yen TC; Hsiao IT
    Front Aging Neurosci; 2022; 14():857940. PubMed ID: 35721010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parametric estimation of reference signal intensity in the quantification of amyloid-beta deposition: an
    Wang M; Yan Z; Zhang H; Lu J; Li L; Yu J; Wang J; Matsuda H; Zuo C; Jiang J;
    Quant Imaging Med Surg; 2021 Jan; 11(1):249-263. PubMed ID: 33392026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau PET With
    Huang CC; Hsiao IT; Huang CY; Weng YC; Huang KL; Liu CH; Chang TY; Wu HC; Yen TC; Lin KJ
    Front Neurol; 2019; 10():503. PubMed ID: 31191427
    [No Abstract]   [Full Text] [Related]  

  • 8. The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.
    Aghakhanyan G; Vergallo A; Gennaro M; Mazzarri S; Guidoccio F; Radicchi C; Ceravolo R; Tognoni G; Bonuccelli U; Volterrani D
    Neurodegener Dis; 2018; 18(5-6):302-309. PubMed ID: 30814473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-phase
    Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
    Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
    J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Aβ analysis using magnetically-labeled immunoassays and PET
    Wu KY; Hsiao IT; Chen CH; Liu CY; Hsu JL; Huang SY; Yen TC; Lin KJ
    Sci Rep; 2018 Feb; 8(1):2739. PubMed ID: 29426824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
    Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrophy, hypometabolism and implication regarding pathology in late-life major depression with suspected non-alzheimer pathophysiology (SNAP).
    Wu KY; Lin KJ; Chen CH; Liu CY; Wu YM; Yen TC; Hsiao IT
    Biomed J; 2023 Dec; 46(6):100589. PubMed ID: 36914051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of increased brain amyloid in severe TBI survivors at 1, 12, and 24 months after injury: report of 2 cases.
    Gatson JW; Stebbins C; Mathews D; Harris TS; Madden C; Batjer H; Diaz-Arrastia R; Minei JP
    J Neurosurg; 2016 Jun; 124(6):1646-53. PubMed ID: 26613169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease.
    Ketter N; Liu E; Di J; Honig LS; Lu M; Novak G; Werth J; LePrince Leterme G; Shadman A; Brashear HR
    J Prev Alzheimers Dis; 2016; 3(4):192-201. PubMed ID: 29199321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid imaging with [(18)F]florbetapir in geriatric depression: early-onset versus late-onset.
    Tateno A; Sakayori T; Higuchi M; Suhara T; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 Jul; 30(7):720-8. PubMed ID: 25335941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.